Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Market Size Breakdown by Segment
1.5.1 Market Segmentation by Purity
1.5.2 Market Segmentation by Application
1.5.3 Market Segmentation by Technology
1.5.4 Market Segmentation by End User
1.5.5 Market Segmentation by Geography
1.6 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 P&S Intelligence Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Industry Participant
2.2.2 Breakdown of Primary Research, by Designation
2.2.3 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Definition of Market Segments
4.1 By Product
4.1.1 By Purity
4.1.1.1 Up to 75%
4.1.1.2 76–90%
4.1.1.3 Above 90%
4.1.2 By Application
4.1.2.1 Peptide therapeutics
4.1.2.2 Antibody production
4.1.2.3 Biomarker discovery
4.1.2.4 Isotopic labeling
4.1.2.5 Protein production
4.1.2.6 Cosmetics development
4.1.2.7 Others
4.1.3 By Technology
4.1.3.1 SPPS
4.1.3.2 LPPS
4.1.3.3 Hybrid
4.1.4 By End User
4.1.4.1 Pharmaceutical & biotechnology companies
4.1.4.2 Research institutes
4.1.4.3 Others
Chapter 5. Industry Outlook
5.1 U.S. Market Dynamics
5.1.1 Trends
5.1.1.1 Advancements in technology
5.1.1.2 Increasing applications in therapeutics and diagnostics
5.1.2 Drivers
5.1.2.1 Expanding biotechnology and pharmaceutical industries
5.1.2.2 Growing demand for personalized medicine
5.1.2.3 Increasing focus on cancer and infectious disease research
5.1.3 Impact Analysis of Drivers on Market Forecast
5.1.4 Restraints
5.1.4.1 High cost associated with peptide production
5.1.4.2 Technical challenges impacting efficiency and reliability of peptide production
5.1.5 Impact Analysis of Restraints on Market Forecast
5.1.6 Opportunities
5.1.6.1 Development of peptide-based therapeutics
5.1.6.2 Expansion into new research areas
5.2 EU Market Dynamics
5.2.1 Trends
5.2.1.1 Growth in research and development activities
5.2.1.2 Focus on ensuring high quality and regulatory compliance
5.2.2 Drivers
5.2.2.1 Strong intellectual property and market protection framework
5.2.2.2 High emphasis on sustainability and green practices
5.2.2.3 Growing demand for personalized medicine and diagnostics
5.2.3 Impact Analysis of Drivers on Market Forecast
5.2.4 Restraints
5.2.4.1 Supply chain disruptions
5.2.4.2 Regulatory and compliance challenges
5.2.5 Impact Analysis of Restraints on Market Forecast
5.2.6 Opportunities
5.2.6.1 Unmet demand in emerging Eastern European markets
5.3 Impact of COVID-19
5.4 Porter’s Five Forces Analysis
5.4.1 Bargaining Power of Buyers
5.4.2 Bargaining Power of Suppliers
5.4.3 Intensity of Rivalry
5.4.4 Threat of New Entrants
5.4.5 Threat of Substitutes
Chapter 6. U.S. Market Size and Forecast
6.1 Overview
6.2 Market Revenue, by Purity (2019–2030)
6.3 Market Revenue, by Application (2019–2030)
6.4 Market Revenue, by Technology (2019–2030)
6.5 Market Revenue, by End User (2019–2030)
Chapter 7. EU Market Size and Forecast
7.1 Overview
7.2 Market Revenue, by Purity (2019–2030)
7.3 Market Revenue, by Application (2019–2030)
7.4 Market Revenue, by Technology (2019–2030)
7.5 Market Revenue, by End User (2019–2030)
7.6 Market Revenue, by Country (2019–2030)
Chapter 8. Germany Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Purity (2019–2030)
8.3 Market Revenue, by Application (2019–2030)
8.4 Market Revenue, by Technology (2019–2030)
8.5 Market Revenue, by End User (2019–2030)
Chapter 9. France Market Size and Forecast
9.1 Overview
9.2 Market Revenue, by Purity (2019–2030)
9.3 Market Revenue, by Application (2019–2030)
9.4 Market Revenue, by Technology (2019–2030)
9.5 Market Revenue, by End User (2019–2030)
Chapter 10. Switzerland Market Size and Forecast
10.1 Overview
10.2 Market Revenue, by Purity (2019–2030)
10.3 Market Revenue, by Application (2019–2030)
10.4 Market Revenue, by Technology (2019–2030)
10.5 Market Revenue, by End User (2019–2030)
Chapter 11. Italy Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Purity (2019–2030)
11.3 Market Revenue, by Application (2019–2030)
11.4 Market Revenue, by Technology (2019–2030)
11.5 Market Revenue, by End User (2019–2030)
Chapter 12. Spain Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Purity (2019–2030)
12.3 Market Revenue, by Application (2019–2030)
12.4 Market Revenue, by Technology (2019–2030)
12.5 Market Revenue, by End User (2019–2030)
Chapter 13. Belgium Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Purity (2019–2030)
13.3 Market Revenue, by Application (2019–2030)
13.4 Market Revenue, by Technology (2019–2030)
13.5 Market Revenue, by End User (2019–2030)
Chapter 14. Netherlands Market Size and Forecast
14.1 Overview
14.2 Market Revenue, by Purity (2019–2030)
14.3 Market Revenue, by Application (2019–2030)
14.4 Market Revenue, by Technology (2019–2030)
14.5 Market Revenue, by End User (2019–2030)
Chapter 15. Denmark Market Size and Forecast
15.1 Overview
15.2 Market Revenue, by Purity (2019–2030)
15.3 Market Revenue, by Application (2019–2030)
15.4 Market Revenue, by Technology (2019–2030)
15.5 Market Revenue, by End User (2019–2030)
Chapter 16. Poland Market Size and Forecast
16.1 Overview
16.2 Market Revenue, by Purity (2019–2030)
16.3 Market Revenue, by Application (2019–2030)
16.4 Market Revenue, by Technology (2019–2030)
16.5 Market Revenue, by End User (2019–2030)
Chapter 17. Sweden Market Size and Forecast
17.1 Overview
17.2 Market Revenue, by Purity (2019–2030)
17.3 Market Revenue, by Application (2019–2030)
17.4 Market Revenue, by Technology (2019–2030)
17.5 Market Revenue, by End User (2019–2030)
Chapter 18. Austria Market Size and Forecast
18.1 Overview
18.2 Market Revenue, by Purity (2019–2030)
18.3 Market Revenue, by Application (2019–2030)
18.4 Market Revenue, by Technology (2019–2030)
18.5 Market Revenue, by End User (2019–2030)
Chapter 19. Competitive Landscape
19.1 List of Market Players and Their Offerings
19.2 Recent Strategic Developments of Key Players
19.2.1 Product Launches and Approvals
19.2.2 Partnerships and Collaborations
19.2.3 Facility Expansion
19.2.4 Other Developments
Chapter 20. Company Profiles
20.1 GenScript Biotech Corporation
20.1.1 Business Overview
20.1.2 Product and Service Offerings
20.1.3 Key Financial Summary
20.2 Intavis Peptide Services GmbH
20.2.1 Business Overview
20.2.2 Product and Service Offerings
20.3 PolyPeptide Group AG
20.3.1 Business Overview
20.3.2 Product and Service Offerings
20.3.3 Key Financial Summary
20.4 RS Synthesis
20.4.1 Business Overview
20.4.2 Product and Service Offerings
20.5 21st Century Biochemicals Inc.
20.5.1 Business Overview
20.5.2 Product and Service Offerings
20.6 Advanced ChemTech
20.6.1 Business Overview
20.6.2 Product and Service Offerings
20.7 Peptide 2.0 Inc.
20.7.1 Business Overview
20.7.2 Product and Service Offerings
20.8 BCNPeptides S.A.U.
20.8.1 Business Overview
20.8.2 Product and Service Offerings
20.9 Schafer-N ApS
20.9.1 Business Overview
20.9.2 Product and Service Offerings
20.10 Synbio Technologies
20.10.1 Business Overview
20.10.2 Product and Service Offerings
20.11 AAPPTec LLC
20.11.1 Business Overview
20.11.2 Product and Service Offerings
20.12 Abcepta Inc.
20.12.1 Business Overview
20.12.2 Product and Service Offerings
20.13 Bachem AG
20.13.1 Business Overview
20.13.2 Product and Service Offerings
20.13.3 Key Financial Summary
20.14 Merck KGaA
20.14.1 Business Overview
20.14.2 Product and Service Offerings
20.14.3 Key Financial Summary
20.15 JPT Peptide Technologies GmbH
20.15.1 Business Overview
20.15.2 Product and Service Offerings
20.16 Biosynth Ltd.
20.16.1 Business Overview
20.16.2 Product and Service Offerings
20.17 Almac Group Limited
20.17.1 Business Overview
20.17.2 Product and Service Offerings
20.18 CSBio
20.18.1 Business Overview
20.18.2 Product and Service Offerings
20.19 Applied Biological USA Materials Inc.
20.19.1 Business Overview
20.19.2 Product and Service Offerings
20.20 Thermo Fisher Scientific Inc.
20.20.1 Business Overview
20.20.2 Product and Service Offerings
20.20.3 Key Financial Summary
20.21 BIOSYNTAN GmbH
20.21.1 Business Overview
20.21.2 Product and Service Offerings
20.22 CASLO ApS
20.22.1 Business Overview
20.22.2 Product and Service Offerings
20.23 Covalab Inc.
20.23.1 Business Overview
20.23.2 Product and Service Offerings
20.24 AmbioPharm Inc.
20.24.1 Business Overview
20.24.2 Product and Service Offerings
20.25 Biomatik Corporation
20.25.1 Business Overview
20.25.2 Product and Service Offerings
20.26 AnaSpec
20.26.1 Business Overview
20.26.2 Product and Service Offerings
20.27 Creative Proteomics
20.27.1 Business Overview
20.27.2 Product and Service Offerings
20.28 Elabscience Bionovation Inc.
20.28.1 Business Overview
20.28.2 Product and Service Offerings
20.29 Kaneka Eurogentec S.A.
20.29.1 Business Overview
20.29.2 Product and Service Offerings
20.3 Genosphere Biotechnologies
20.30.1 Business Overview
20.30.2 Product and Service Offerings
20.31 mk2 Biotechnologies GmbH
20.31.1 Business Overview
20.31.2 Product and Service Offerings
20.32 WuXi TIDES
20.32.1 Business Overview
20.32.2 Product and Service Offerings
20.33 Davids Biotechnologie GmbH
20.33.1 Business Overview
20.33.2 Product and Service Offerings
Chapter 21. Appendix
21.1 Sources and References
21.2 Related Reports
List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 Drivers for The u.s. Market: Impact Analysis
TABLE 3 restraints for The U.S. Market: Impact Analysis
TABLE 4 Drivers for The EU Market: Impact Analysis
TABLE 5 restraints for The EU Market: Impact Analysis
TABLE 6 U.S. custom peptide synthesis services market Revenue, BY purity, $M (2019–2024)
TABLE 7 U.S. custom peptide synthesis services market Revenue, BY purity, $M (2025–2030)
TABLE 8 U.S. custom peptide synthesis services market Revenue, BY Application, $M (2019–2024)
TABLE 9 U.S. custom peptide synthesis services market Revenue, BY Application, $M (2025–2030)
TABLE 10 U.S. custom peptide synthesis services market Revenue, BY Technology, $M (2019–2024)
TABLE 11 U.S. custom peptide synthesis services market Revenue, BY Technology, $M (2025–2030)
TABLE 12 U.S. custom peptide synthesis services market Revenue, BY End User, $M (2019–2024)
TABLE 13 U.S. custom peptide synthesis services market Revenue, BY End User, $M (2025–2030)
TABLE 14 EU custom peptide synthesis services market Revenue, BY purity, $M (2019–2024)
TABLE 15 EU custom peptide synthesis services market Revenue, BY purity, $M (2025–2030)
TABLE 16 EU custom peptide synthesis services market Revenue, BY Application, $M (2019–2024)
TABLE 17 EU custom peptide synthesis services market Revenue, BY Application, $M (2025–2030)
Want a report tailored exactly to your business need?
Request CustomizationEmpowering Leaders Across the Globe
Leading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages